New Active and International members elected for 2024

The ASCI is pleased to announce the election of 100 Active and International members for 2024.

These new members come from 50 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 5, 2024, as part of the AAP/ASCI/APSA Joint Meeting, April 5–7, at the Swissotel Chicago.

The 2024 Active and International members:

MemberInstitution
Allison Lorna Agwu, MD, ScMJohns Hopkins University School of Medicine
Cristina Maria Alvira, MDStanford University School of Medicine
Liana Apostolova, MD, MScIndiana University School of Medicine
Pankaj Arora, MD, FAHA, FASEUniversity of Alabama at Birmingham School of Medicine
Ruanne Vanessa Barnabas, MBChB, MSc, DPhilHarvard Medical School, Massachusetts General Hospital
Miles Berger, MD, PhDDuke University School of Medicine
Arthur Beyder, MD, PhDMayo Clinic
Mitesh Jivraj Borad, MDMayo Clinic
Angela R. Bradbury, MDUniversity of Pennsylvania Perelman School of Medicine
Jonathan D. Brown, MDVanderbilt University School of Medicine
James Edward Cassat, MD, PhDVanderbilt University School of Medicine
Lilia Cervantes, MD, MSCSUniversity of Colorado School of Medicine
Lin Yee Chen, MBBS, MSUniversity of Minnesota Medical School
Matthew Aaron Ciorba, MDWashington University School of Medicine in St. Louis
Scott M. Damrauer, MDUniversity of Pennsylvania Perelman School of Medicine
John P. Dekker, MD, PhDNational Institutes of Health
Evan Samuel Dellon, MD, MPHUniversity of North Carolina School of Medicine
Robert Pickett Dickson, MDUniversity of Michigan Medical School
Nico Urs Felix Dosenbach, MD, PhDWashington University School of Medicine in St. Louis
Vikas Dudeja, MBBS, FACSUniversity of Alabama at Birmingham School of Medicine
Jeffrey D. Dvorin, MD, PhDHarvard Medical School, Boston Children's Hospital
E. Jennifer Edelman, MD, MHSYale School of Medicine
Susan D. Emmett, MD, MPHUniversity of Arkansas College of Medicine
Michelle Mae Estrella, MD, MHSUniversity of California, San Francisco, School of Medicine
Carmella Evans-Molina, MD, PhDIndiana University School of Medicine
Amani A. Fawzi, MD, MSc, DScNorthwestern University Feinberg School of Medicine
Courtney Dayle Fitzhugh, MDNIH, National Heart, Lung, and Blood Institute (NHLBI)
Elizabeth E. Foglia, MD, MSCEUniversity of Pennsylvania Perelman School of Medicine
Karunesh Ganguly, MD, PhDUniversity of California, San Francisco, School of Medicine
Marcus DaSilva Goncalves, MD, PhDWeill Cornell Medicine
Monika Kumari Goyal, MD, MSCEGeorge Washington University School of Medicine & Health Sciences
Peter Christopher Grayson, MD, MScNIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Kira Gritsman, MD, PhDAlbert Einstein College of Medicine
David Sullivan Hains, MD, MBAIndiana University School of Medicine
Brent A. Hanks, MD, PhDDuke University Medical Center
Tamia A. Harris-Tryon, MD, PhDUniversity of Texas Southwestern Medical Center
Jeffrey A. Haspel, MD, PhDWashington University School of Medicine in St. Louis
Timothy Jensen Henrich, MD, MMScUniversity of California, San Francisco, School of Medicine
Christian S. Hinrichs, MDRutgers, Robert Wood Johnson Medical School
Jennifer En-Sian Ho, MDHarvard Medical School, Beth Israel Deaconess Medical Center
Craig Michael Horbinski, MD, PhDNorthwestern University Feinberg School of Medicine
Christopher Simon Hourigan, DM, DPhil, FRCPNational Institutes of Health
Sohail Z. Husain, MDStanford University School of Medicine
Samar H. Ibrahim, MBChBMayo Clinic
Rodney Elwood Infante, MD, PhDUniversity of Texas Southwestern Medical Center
Daniel J. Jackson, MDUniversity of Wisconsin School of Medicine and Public Health
Joanne Michelle Kahlenberg, MD, PhDUniversity of Michigan Medical School
Kiran Kaur Khush, MD, MAS, FACCStanford University School of Medicine
Betty Y.S. Kim, MD, PhD, FRCSC, FAANSUniversity of Texas MD Anderson Cancer Center
Dae Hyun Kim, MD, MPH, ScDHarvard Medical School, Beth Israel Deaconess Medical Center
Justin Paul Kline, MDUniversity of Chicago Medical Center
Frederick Kofi Korley, MD, PhDUniversity of Michigan Medical School
Carl Koschmann, MDUniversity of Michigan Medical School
Elaine Ku, MD, MASUniversity of California, San Francisco, School of Medicine
Li Lan, MD, PhDDuke University School of Medicine
Charles Regis Langelier, MD, PhDUniversity of California, San Francisco, School of Medicine
John Kyung Lee, MD, PhDUniversity of California, Los Angeles, David Geffen School of Medicine
Jung-Min Lee, MDNIH, National Cancer Institute (NCI)
JoAnna Kristine Leyenaar, MD, PhD, MPHDartmouth Geisel School of Medicine
Kian-Huat Lim, MD, PhDWashington University School of Medicine in St. Louis
Robert Coleman Lindsley, MD, PhDHarvard Medical School, Dana-Farber Cancer Institute
Elizabeth Dawn Lowenthal, MD, MSCEChildren's Hospital of Philadelphia
Jeffrey A. Magee, MD, PhDWashington University School of Medicine in St. Louis
Steven E. Mansoor, MD, PhDOregon Health & Science University
Rozalina G. McCoy, MD, MSUniversity of Maryland School of Medicine
Reena Mehra, MD, MSCleveland Clinic
Madhav Chandrasekhar Menon, MD, MBBSYale School of Medicine
Jonathan J. Miner, MD, PhDUniversity of Pennsylvania Perelman School of Medicine
Kent William Mouw, MD, PhDHarvard Medical School, Dana-Farber Cancer Institute
Nikhil Vilas Munshi, MD, PhDUniversity of Texas Southwestern Medical Center
Samir Sunil Parekh, MDIcahn School of Medicine at Mount Sinai
Jonathan B. Parr, MD, MPHUniversity of North Carolina School of Medicine
William Hughes Peranteau, MDChildren's Hospital of Philadelphia
Craig Evan Pollack, MD, MHSJohns Hopkins Bloomberg School of Public Health
Read Pukkila-Worley, MDUniversity of Massachusetts Medical School
Babak Razani, MD, PhDUniversity of Pittsburgh School of Medicine
Armin Raznahan, MD, PhD, MRCPCH, MRCPsychNIH, National Institute of Mental Health (NIMH)
Nadine Rouphael, MD, MSc, FSSCI, FIDSAEmory University School of Medicine
Takeshi Saito, MD, PhD, FAGAUniversity of Southern California Keck School of Medicine
Matthew G. Sampson, MD, MSCEHarvard Medical School, Boston Children's Hospital
Tiffany C. Scharschmidt, MDUniversity of California, San Francisco, School of Medicine
John Alexis Schneider, MD, MPHUniversity of Chicago Medical Center
Matthew Semler, MD, MScVanderbilt University School of Medicine
Amil Madhukar Shah, MD, MPHUniversity of Texas Southwestern Medical Center
N. Sarita Shah, MD MPHEmory University School of Medicine
Sanjiv J. Shah, MDNorthwestern University Feinberg School of Medicine
Benjamin David Singer, MDNorthwestern University Feinberg School of Medicine
Douglas R. Stewart, MDNIH, National Cancer Institute (NCI)
Steve Myer Taylor, MD, MPHDuke University School of Medicine
Zian Huan Tseng, MD, MASUniversity of California, San Francisco, School of Medicine
Miguel Valderrabano, MD, PhDHouston Methodist, Texas Medical Center
Sriram Venneti, MD, PhDUniversity of Michigan Medical School
Sushrut S. Waikar, MD, MPHBoston University School of Medicine
Yinghong (Mimi) Wang, MD, PhD, MScUniversity of Texas MD Anderson Cancer Center
Arun Paul Wiita, MD, PhDUniversity of California, San Francisco, School of Medicine
F. Perry Wilson, MD MSCEYale School of Medicine
Alexi A. Wright, MD, MPHHarvard Medical School, Dana-Farber Cancer Institute
Rona D. Yaeger, MDMemorial Sloan Kettering Cancer Center
Robert W. Yeh, MD, MSc, MBAHarvard Medical School, Beth Israel Deaconess Medical Center
Jindan Yu, MD, PhDEmory University School of Medicine

For the 2024 Active and International membership nomination cycle, the Council received and considered 302 nominations, from which it recommended 100 nominees (the maximum) for election. The Active, International, and Senior segments of the membership voted on the recommendation from November 29 through December 6, with 43% of eligible voters submitting their ballots. The vote was overwhelmingly in favor of approving the recommendation. Dr. Elizabeth Speliotes, in her role as the ASCI’s 2023–2025 Secretary-Treasurer, oversaw auditing of the ballot. Drs. Benjamin Humphreys and Priscilla Hsue served as auditors.

Nominations for ASCI Council, 2024

The Society seeks nominations for the following ASCI Council vacancies arising in 2023 (all terms begin and end in the spring):

  • Vice President (4-year term, 2024-2028)
  • Secretary-Treasurer Elect (3-year term, 2022-2025; first year is Councilor position, transitioning to Secretary-Treasurer for years 2 and 3)
  • Councilor (one position, 3-year term, 2024-2027)

Those eligible for nomination must be in the Active category and:

  • for Vice President, do not turn 56 until 2029 or later
  • for other positions, do not turn 56 until 2028 or later

The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by January 16, 2024, at 11:59 PM EST.

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and Stanley J. Korsmeyer Award nominations and subsequent discussion at the fall meeting.

The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

Nominators:

  • may be any ASCI member
  • must provide a statement (250-word limit) regarding the nominee

Nominees:

  • must specify the position of interest (Vice President, Secretary-Treasurer Elect, Councilor);
  • must provide the following:
    • a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate. The nominee must provide the statement by email to staff@the-asci.org by the deadline noted above. (Nominees may refer to candidate statements for the 2022 nomination cycle for guidance in drafting their own statements.)
    • an NIH-style biosketch;
  • and must complete the ASCI’s demographic survey.

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Council nominations”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

Nominations open for 2024 Honorary membership

The ASCI is pleased to call for nominations for 2024 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

For the nominee who meets these criteria, there is no restriction on age or degree held.

The deadline for receipt of nominations is January 16, 2024, at 11:59 pm Eastern (extended from December 8 , 2023). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

Nominators:

  • must be an ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • must provide a full curriculum vitae and
  • must complete the ASCI’s demographic survey.

To start a nomination:

The nominator must initiate the process:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Honorary membership”:
    • Select “I’m the nominator” option
    • Search for your nominee:
      • If found, click on “Create nomination”.
      • If no result is found, enter the requested information (first name, last name, and email address), save, and then click on “Create nomination”.
    • At the top of the nomination form, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).

 

Call for applications to ASCI’s Postbac Program

The ASCI is pleased to call for applications for the Society’s new Postbac Program.

This program provides an intensive, two-year mentored laboratory research experience for students that will expose them to the physician-scientist career path, strengthen their applications to MD or MD-PhD programs, and enhance their career development.

From the applicants, two finalists will be selected and each matched with a host lab where the Principal Investigator is an ASCI member with an outstanding mentoring record and resources to ensure in-depth research training. The two-year period will be mid-2024 through mid-2026.

Applicants are college graduates who are either in their last year of undergraduate study or received their bachelor’s degree within TWO years at the time of submission. Applicants should intend to apply to medical school during their second year of the Postbac Program.

Applications consist of:

  • a 750-word essay that describes your research experience, current interests and career goals, and anything else you would like us to know about you;
  • an undergraduate transcript (PDF);
  • a curriculum vitae (PDF);
  • headshot photograph (JPG etc.) (this file is not used in the review process);
  • two letters of recommendation (see more below); and
  • a completed ASCI demographics survey.

The application deadline is March 4, 2024, at 11:59 pm Eastern (extended from February 16). See the Postbac Program FAQ section for additional key dates.

Interested in applying?

Email staff@the-asci.org to request that an application be set up. You’ll receive an email providing information to access your application.

  • You can return to and edit the application until you’ve submitted it.
  • If you submit the application before the deadline and wish to edit it, email us and we’ll reopen the application.

Letters of recommendation

In your application, you’ll see a “Letters of recommendation” section where you can look up your supporters and add them if not found in our database. Supporters do not need to be affiliated with the ASCI in any way.

You’re responsible for notifying supporters to provide their letters online. Supporters are asked to complete two sections:

  • a statement (500-word limit) detailing your strengths and suitability to this program; and
  • a brief statement regarding their relationship to you.

Note that you won’t be able to submit your application until you’ve notified your supporters. In this section, you’ll be able to see whether supporters’ forms are in progress or submitted. You’ll also receive an email notification when each supporter submits her/his form.

Call for volunteer: Chair of the new Philanthropy Committee

The ASCI seeks a volunteer to chair a newly established Philanthropy Committee.

The ideal volunteer ASCI member will help establish and nurture potential donors to the organization. The goal is to obtain major gifts that can be used to support the mission of the ASCI, including but not limited to supporting scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve the health of our communities.

As part of this mission, the ASCI provides two programs for early-career physician-scientists: the Young Physician-Scientist Awards (YPSAs), for those who are within 5 years of their first faculty appointment, and the Emerging-Generation (E-Gen) Awards, for those who are within 3 to 9 years of earning their MD, MD/PhD, or equivalent degrees. Both the YPSAs and E-Gen Awards are intended to connect early-career physician-scientists with the ASCI community through access to the annual AAP/ASCI/APSA Joint Meeting and virtual career development, mentorship, and networking opportunities.

This year, the ASCI has initiated a new program, the ASCI Postbac Program, that will support Underrepresented in Medicine and Science (UiMS) students in obtaining an intensive, mentored, laboratory research experience. The goal of this program is to expose students to the physician-scientist career pathway and strengthen their applications to MD or MD/PhD programs.

The Society envisions expanding these programs further to support the careers of physician-scientists, and the Philanthropy Committee Chair will play a critical role in these efforts.

The Chair will serve an initial 3-year term, joined by a Vice Chair (the current ASCI Secretary-Treasurer) and other ex-officio Council members. In addition, the Chair will be supported by other non-Council volunteer members (to be selected by the Chair with approval of the President) and ASCI staff. As part of donor cultivation, the Chair will be host of an annual donor-recognition dinner in Chicago on the evening prior to the start of the Joint Meeting.

The ASCI anticipates the effort for the Chair to be approximately 5 hours per month. The ASCI will provide reimbursement for travel and related expenses accrued for Committee work, including registration, hotel, and travel for the Joint Meeting.

Those interested should send a CV and a brief (~250-word) statement of interest, including relevant experience, by November 6 to staff@the-asci.org.

Nominations open for mid-career member awards, 2024

The ASCI is pleased to call for nominations for awards recognizing the scholarly achievements of mid-career members:

The Marian W. Ropes, MD, Award recognizes a middle-career woman physician-scientist. The annual award honors Dr. Ropes (1903–1994), a pioneer both as a researcher on the role of synovial fluid in joint diseases and as a woman in academic medicine. She was the first woman documented to have been elected to the ASCI. The recipient of this award receives a $10,000 honorarium, will be recognized at the ASCI’s 2024 annual meeting, and gives the Ropes Lecture at the 2025 meeting.

The Louis W. Sullivan, MD, Award recognizes a middle-career physician-scientist who is underrepresented in medicine and science. The award honors Dr. Sullivan (born 1933), a hematologist, health care advocate, and policy leader — having served as US Secretary of Health and Human Services — and who was the first Black physician-scientist elected to the ASCI. The recipient of this award receives a $10,000 honorarium, will be recognized at the ASCI’s 2024 annual meeting, and gives the Sullivan Lecture at the 2025 meeting.

ASCI members who were elected in 2019 or more recently may be nominated. Additionally:

  • For the Ropes Award, only female members are eligible for nomination.
  • For the Sullivan Award, only UiMS members are eligible for nomination.

The deadline for receipt of nominations is November 27, 2023, at 11:59 pm Eastern (extended from November 13). Nominations will be screened to ensure they are complete and fit the award criteria. The ASCI’s Diversity, Equity, and Inclusion Committee will review nominations and submit its recommendations to the ASCI Council for approval. We expect to notify nominees about the outcome by January 2024.

Nominators:

  • must be an ASCI member, except for current members of the ASCI Council and the ASCI Diversity, Equity, and Inclusion Committee, and
  • must provide a statement regarding the nominee (500-word limit).

Nominees:

  • must fit the criteria noted above and may not be current members of the ASCI Council and the ASCI Diversity, Equity, and Inclusion Committee;
  • may be nominated only for one ASCI award (for example, a nominee for the Ropes Award may not be nominated for the Sullivan Award, Korsmeyer Award, or Harrington Prize);
  • must provide the following:
    • a personal statement (750-word limit) on their scientific achievements, with attention to relevant personal and career history (including a statement of diversity), mentoring experience, and service to the community;
    • a full curriculum vitae; and
    • 3 most-significant publications, each with a 50-word annotation, followed by the member’s role in the publication, the journal name and publication year, and the Pubmed ID noted as “PMID:12345”;
  • and must complete the ASCI’s demographic survey.

To start a nomination:

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for the award of interest:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information); note that this option will not be available for the Ropes Award for male members.
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who were elected starting 2019 will appear in the results. Note: for the Ropes Award, you will only be able to select a nominee who is a woman; for the Sullivan Award, you may select anyone who is within the election-year window, but nominations will be screened (based on the information the nominee provides in the demographics survey) to ensure that nominees fit the UiMS criterion.

Definition of UiMS

The ASCI defines underrepresented in medicine in science as follows: Underrepresented in medicine and science (UiMS) refers to populations that are underrepresented relative to their numbers in the general US population. This includes, but is not necessarily limited to, physician-scientists who identify in the following racial and/or ethnic groups: Black/African American, Hispanic or Latin American, Native American/American Indian or Alaska Native, and Native Hawaiian and other Pacific Islander; individuals with disabilities: physical or mental impairment that substantially limits one or more major life activities; and those with an educationally or financially disadvantaged background.

Nominations open for the 2024 ASCI / Stanley J. Korsmeyer Award

Nominations for the ASCI’s 2024 ASCI / Stanley J. Korsmeyer Award are now open.

This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

The deadline for receipt of nominations is October 25, 2023, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2023.

Nominators:

  • may be any ASCI member in good standing, including members of the Council, and
  • must provide a statement (250-word limit) regarding the nominee.

Nominees:

  • must currently be an Active or International member (age 55 or younger);
  • must provide a biosketch, full curriculum vitae, and a trainee table; and
  • must complete the ASCI’s demographic survey.

To start a nomination:

Nominations may be started by the nominator or the nominee:

  • Access your member account
  • Go to the “Activities / nominations” tab
  • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

 

For the nominator:

  • Select “I’m the nominator” option
  • Search for your nominee
  • Click on “Create nomination”
  • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
  • Supply the required information (see above)
  • Submit this aspect of the nomination

For the nominee:

  • Select “I’m the nominee” option
  • Supply the required information (see above)
  • Submit this aspect of the nomination

Nominations open for the 2024 Seldin~Smith Award for Pioneering Research

The ASCI is pleased to call for nominations for the 2024 Seldin~Smith Award for Pioneering Research. The annual award, accompanied by an unrestricted $30,000 grant to advance academic efforts, honors an early-career physician-scientist who has demonstrated exceptional creativity and accomplishments in biomedical research (see past recipients).

The deadline for receipt of nominations is Monday, November 27, at 11:59 pm Eastern (extended from October 31).

The nominee:

  • must be an MD (or the equivalent);
  • must be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment as of April 2024; and
  • spends substantial time in research while providing direct patient care.

A nomination must be started by the nominator, who then notifies the nominee to complete her/his part of the nomination. The nominee identifies the supporter of the nomination and notifies that person through the submission site to complete her/his support form.

Nominations will be screened to ensure they are complete and fit the nomination criteria. The Seldin~Smith Award Selection Committee reviews nominations and provides recommendations to the Seldin~Smith Award Advisory Committee to determine the recipient.

The nominator must be an ASCI member in good standing and must start the nomination:

  • Access your member account
  • Go to the “Nominations” tab, then to the “ASCI / Seldin~Smith Award for Pioneering Research” section
  • Select “I’m the nominator” option
  • Search for your nominee:
    • If found, click on “Create nomination”
    • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Create nomination” for the newly created nominee in the “Results” section
  • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
  • Provide a 500-word limit statement on the nominee’s most significant achievement
  • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

The nominee receives an email with information to access her/his part of the nomination and then must:

  • Provide a birth date and address information
  • Provide a summary (100-word limit) of her/his research, followed by a notation of the percentage of time devoted to direct patient care
  • Provide detail of:
    • Degrees obtained
      • Year of first faculty or equivalent appointment
    • Current institutional affiliation
  • Upload:
    • Current NIH-style biosketch
    • Three significant publications, each with an annotation (100-word limit)
  • Identify the nomination’s supporter and sends notification to the supporter to access her/his support form
  • Complete a demographic profile
  • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed her/his statement

The supporter:

  • Does not need to be an ASCI member
  • Must be identified and notified by the nominee
  • Provides a statement (500-word limit) of the nominee’s research contributions (the statement should be distinct from that of the nominator)

On health equity in the physician-scientist workforce

Sherita Hill Golden, MD, MHS
Dr. Golden

The US Supreme Court’s recent decision to eliminate affirmative action in college admissions has begun a process of dismantling decades of progress toward creating a more equitable society. The long-term effects of these decisions will be a country that’s more polarized and more divided, and at the same time less healthy. Attracting diverse candidates to the physician-scientist workforce and ensuring their career longevity will become even harder. In turn, science and medicine that does not represent the perspectives, expertise, and creativity of our diverse population won’t as readily identify health and health-care disparities or develop innovative solutions to achieve health equity.

The jeopardy to those who are minoritized or marginalized is real. It’s a sad moment in which we find ourselves: although legal precedent — while diminished — would suggest continued equitable access and consideration, those who have been systematically disenfranchised face increased obstacles in light of the rulings.

We must all continue to advocate for justice and speak up for equity in whatever sphere we find ourselves. As the 2023–2025 Chair of the ASCI’s Diversity, Equity, and Inclusion Committee (DEIC), I’m proud of the many initiatives we’ve seen through since the Committee’s creation in October 2020. I’ll continue to work with our enthusiastic Committee members and the ASCI Council to ensure that the Society is truly representative.

Expanding on the ASCI’s commitment to diversity, equity, and inclusion, I’m pleased to announce the ASCI’s Postbac Program. Ben Humphreys, the ASCI’s 2023–2024 President, conceived the program, and the ASCI Council enthusiastically approved initial funds to ensure its success while we seek philanthropic support to expand the initiative.

The program provides an intensive two-year mentored laboratory research experience for students that will expose them to the physician-scientist career path, strengthen their applications to MD or MD/PhD programs, and enhance their career development. We have opened submissions for member host labs (see below) and in mid-September will call for applications to the program. We look forward to your engagement in this important effort.

Sherita Hill Golden, MD, MHS
On behalf of the DEIC and the ASCI Council

Call for host lab submissions

As part of the ASCI’s new Postbac Program, the ASCI is pleased to call for submissions from Society members who are interested in their labs serving as hosts for Program finalists for 2024–2026. Any member can provide a submission, provided dues are current (if applicable). The deadline for submissions is September 29, 2023, 11:59 pm Eastern.

https://beta.the-asci.org/news/postbac-program/7390/

Call for submissions: ASCI member host labs, 2024–2026

As part of the ASCI’s new Postbac Program, the ASCI is pleased to call for submissions from Society members who are interested in their labs serving as hosts for Program finalists for 2024–2026.

Any member can provide a submission by:

The deadline for submissions is October 10, 2023, 11:59 pm Eastern (extended from September 29).

Submissions consist of the following sections:

  • Your information
    • Your institution
    • Your trainee table (PDF upload); indicate UiMS mentees and if support was from a diversity supplement
  • About your lab
    • Lab website
    • Lab description and environment (500-word limit). Provide detail on mentoring awards, motivation for applying, and mentorship plan (what presentation will be expected, feedback provided, and participation).
    • Lab member who would be assigned for day-to-day mentoring of the postbac (name, position)
    • Assignee’s biosketch (PDF upload)
  • Institutional resources
    • Provide detail on aspects such as the requisite amount of bench/desk space in lab, faculty member to work with student on medical-school essay, institutional career development, and educational and networking opportunities.
    • Institutional stipend levels. The ASCI expects stipends to fall within the ranges of the NIH post-bac IRTA program, with the understanding that the cost of living ranges widely depending on location. Provide information for 2024–2025 and 2025–2026.
    • Indicate if you are able to supplement beyond your institution’s stipend amounts or beyond the ASCI’s maximum grant of $55,000 ($50,000 direct; $5,000 indirect).
  • Potential applicant (optional). Provide name and email address for a student who would be a suitable applicant for this program.